PRAP1 has been demonstrated to be a novel p53 target gene that promotes cancer cell resistance to chemotherapy drugs such as 5-fluorouracil (5-FU) by cell cycle arrest to protect cells from apoptosis and contribute to cancer cell survival (60). The gene discussed is TP53; the disease is cancer.